Overview
In this December edition of IPRD Evalueserve’s Newsletter, Legal Watch features the U.S. Supreme Court’s refusal to hear a challenge on patent validity in a case involving the Postal Service, a court order blocking Sun Pharma’s LEQSELVI launch pending a preliminary injunction, and a deep dive into Abolkheir’s critique of the non-obviousness test as a possible logical fallacy. We also examine the Senate Judiciary Subcommittee’s decision to stall two key patent reform bills. In Industry News, we explore how Asia is leading the world in global IP filings, according to WIPO’s latest report, and how the USPTO is banning in-house use of GenAI tools over security concerns. The EU Commission imposes its first-ever fine for patent misuse, with Teva facing a €462.6 million penalty, and Fujitsu earns the Japan Patent Office Commissioner’s Award.
Our Techno Spotlight covers a mysterious compound discovered in American tap water affecting millions, NIH’s new AI tool for patient-centric clinical trial matching, and L&T Technology Services deepening its software product offerings. We also discuss CPG tech leaders prioritizing larger budgets by 2025, health risks from aircraft engine emissions, next-gen safety protocols for oligonucleotide-based therapeutics, Hyundai’s unveiling of a hydrogen car, and Oppo’s infringement of Panasonic’s SEP in the first FRAND ruling by Local Division Mannheim. Stay tuned for more insights as innovation continues to redefine our global landscape!
Stay tuned for even more innovations and insights!
Subscribe to the Newsletter
Dive in and explore the fascinating world of IP and R&D with us.
